Routine blood tests have been a critical diagnostic tool available to the medical community since the 1940s. They are used to diagnose a wide range of ailments including cancer, diabetes, coronary heart disease, and blood disease, all with a high degree of accuracy. However, an accurate blood test that predicts or ...
October 6, 2019
Transcript of the Testimony of Dr. Rudolph Tanzi Joseph P. and Rose F. Kennedy Professor Neurology Harvard Medical School, Vice-Chair, Neurology Co-Director, McCance Center for Brain Health Massachusetts General Hospital Promoting Healthy Aging: Living Your Best Life Long Into Your Golden Years U.S. Senate Special Committee on Aging September 25, 2019 I want to thank ...
October 6, 2019
“For someone with a background in molecular biology and neuroscience, this is like going into outer space.” SANGRAM SISODIA NEUROBIOLOGIST, UNIVERSITY OF CHICAGO In 2014, John Cryan, a professor at University College Cork in Ireland, attended a meeting in California about Alzheimer’s. He was not an expert on dementia. Instead, he ...
March 15, 2019
Rudolph E. Tanzi, Ph.D., Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Director, Genetics and Aging Research Unit, Massachusetts General Hospital The four known Alzheimer’s genes. Over the past several decades, it has become increasingly clear that inheritance plays a major role in Alzheimer’s disease. The roughly 25,000 ...
July 14, 2011
Setting the stage The 10th Annual International Conference on Alzheimer’s Disease/Parkinson’s Disease (AD/PD) was held this March in Barcelona with thousands of researchers from 68 countries attending. Chief among the topics of interest was determining risk for the disease from genetics. The useful source for all things Alzheimer’s, The Alzheimer’s Research ...
April 7, 2011
Meg Smith, Chief Executive Officer Dear Friends, As summer comes to a close, I am delighted to share an update on our progress and achievements dedicated to advancing research in understanding Alzheimer’s disease (AD). Your support and dedication are instrumental in driving our mission forward, and it is with great pride that ...
September 6, 2024
January 19, 2018
2022 Alzheimer’s disease (AD) is the leading cause of dementia in older adults. However, the majority of clinical trials aiming to modify the disease process have failed over the last two decades. This is due, in part, to variation among people with AD in both their clinical features and biological underpinnings. ...
February 18, 2020
Dr. Rudolph Tanzi at Massachusetts General Hospital will lead a research project funded through a collaboration between Cure Alzheimer’s Fund (CAF) and the National Institute of Mental Health (NIMH) to complete the identification of genes affecting risk for Alzheimer’s disease. The Whole Genome Sequencing (WGS) process will go beyond previously ...
May 6, 2013
Getting to a Cure Why do we need a National Strategy? The cost of care for Alzheimer’s patients will overwhelm Medicare and Medicaid if not checked within the next few years. With funding from private and public sources heavily constrained, it is essential to make each research dollar count. There is enough ...
March 26, 2009
